Market Access Opportunities & Challenges: An Exploration of Three Global Trends

Home / Intelligence / Webinars / Market Access Opportunities & Challenges: An Exploration of Three Global Trends

Available On Demand

Join Trinity Life Sciences’ Evidence, Value, Access and Pricing and Cell & Gene Therapy experts for a deeper look at the market access trends that will present the most impactful opportunities and challenges for life sciences organizations in 2023.

This webinar will expand upon the trends discussed in the recently released white paper entitled “Global Market Access Trends: 2022 Edition,” focusing on evolving evidence expectations, increasing price transparency regulation and cell & gene therapy expansion.

Key Webinar Topics

  • How can life sciences organizations meet evolving evidence expectations in the U.S. and Europe?
  • How can the price of pharmaceutical products be successfully negotiated as more stringent price transparency regulation is enforced globally?
  • How can organizations keep pace with the evolving cell and gene therapy pricing and reimbursement landscape as this new technology expands?

Featuring


Complete the form below to view the on-demand webinar.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.

This webinar will be hosted within the ON24 platform, which requires the usage of Javascript and Cookies. Please see ON24’s Privacy Policy for more information.

Related Intelligence

Blog

Rise with the waves: Italy – AIFA restructuring and budget reforms – Stepping into a new (uncertain) future?

Executive Summary The Italian Medicines Agency (AIFA) underwent transformative changes on January 30, 2024, following a much-anticipated reorganization. AIFA’s restructuring has already faced challenges, with the recent resignation of the newly created Scientific and Economic Commission’s (CSE) chairman followed by the appointment of a new acting chairman, highlighting the need for a stable and collaborative […]

 Read More

Webinars

Annual State of Global Market Access Webinar

March 27, 2024 | 12:00 – 12:45 PM ET

Two additional sessions will be offered on March 28:16:00-16:45 (UTC+8:00) – Asia/Shanghai15:00-15:45 CET – Europe/Berlin Trinity Life Sciences is pleased to release our highly anticipated white paper, the Annual State of Global Market Access. This year’s white paper focuses on six key global market access trends and provides payer perspectives on these trends. We explore the […]

 Sign Up Now

White Papers

Annual State of Global Market Access

In 2023, the life sciences industry saw key therapeutic advances in sickle cell disease, obesity/weight management, and Duchenne muscular dystrophy, among others, and the continued approvals of therapies with cutting edge mechanisms, including the first CRISPR therapy. While 2022 was characterized by accelerated development processes and the rapid evolution of therapeutic standards, 2023 featured increased […]

 Read More